Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing

Artificial intelligence (AI) is discussed with increasing frequency across the nucleic acid therapeutics field: it is already productive in early molecular design and in data-rich analytical tasks, and considerably less mature in the steps that connect synthesis to final product quality. In this Fireside Chat, Nucleic Acid Insights convened Srđan Maširević (Computational Biologist and Machine Learning Scientist, A*STAR’s Genome Institute of Singapore) and Bao Zhong Cai (VP, CMC, GondolaBio) to discuss where AI and machine learning (ML) earn a place in oligonucleotide production today, the data and process foundations they depend on, and how far the field is from digital twins, real-time impurity characterization, and autonomous synthesis. This discussion was a spin-off from the Nucleic Acid Insights Special Interest Group held in April 2026 on enhancing the efficiency and sustainability of oligonucleotide manufacturing.

Authors

Institutions

Publication Details

Journal
Nucleic Acid Insights
Published
2026-11-13
DOI
https://doi.org/10.18609/nai.2026.085
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing

Srdan Masirevic, Bao Zhong Cai
2 links
Nucleic Acid Insights
Computational Drug Discovery Methods
article

Fireside chat: AI’s emerging role in oligonucleotide development and manufacturing

Srdan Masirevic, Bao Zhong Cai
article en

Abstract

Artificial intelligence (AI) is discussed with increasing frequency across the nucleic acid therapeutics field: it is already productive in early molecular design and in data-rich analytical tasks, and considerably less mature in the steps that connect synthesis to final product quality. In this Fireside Chat, Nucleic Acid Insights convened Srđan Maširević (Computational Biologist and Machine Learning Scientist, A*STAR’s Genome Institute of Singapore) and Bao Zhong Cai (VP, CMC, GondolaBio) to discuss where AI and machine learning (ML) earn a place in oligonucleotide production today, the data and process foundations they depend on, and how far the field is from digital twins, real-time impurity characterization, and autonomous synthesis. This discussion was a spin-off from the Nucleic Acid Insights Special Interest Group held in April 2026 on enhancing the efficiency and sustainability of oligonucleotide manufacturing.

Nucleic Acid InsightsVol. 3(9)
Agency for Science, Technology and Research (SG), A*STAR Research Entities (SG), Genome Institute of Singapore (SG)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon